Search alternatives:
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20861
-
20862
-
20863
-
20864
-
20865
Related to Fig 1.
Published 2025“…(<b>J</b>–<b>M</b>) Immunoblot confirms silencing of UGCG in MCF-7 and BT-474 cells (J, L) and cell proliferation assay demonstrates a decrease in proliferation in MCF-7_UGCG<sup>SL</sup> and BT-474_UGCG<sup>SL</sup> cells over MCF-7_SCRAM<sup>SL</sup> (mean ± SEM, <i>n</i> = 5) and BT-474_SCRAM<sup>SL</sup> cells (mean ± SEM, <i>n</i> = 3) (K, M). …”
-
20866
LiCl administered via 0.5% LiCl food pellets for 8 wks decreases GFAP levels in surviving <i>Gfap</i>-R236H/+ mice.
Published 2015“…<p>(A) 81.8% (9/11) +/+ mice and 54.5% (6/11) R236H/+ mice survived 8 wks of LiCl treatment. …”
-
20867
LiCl administered via 0.5% LiCl food pellets for 4 wks decreases GFAP levels in <i>Gfap</i>-R236H/+ mice.
Published 2015“…<p>(A) Survival analysis for mice treated with 0.5% LiCl in food pellets for 4 wks. 94.7% (36/38) R236H/+ mice survived LiCl treatment while 100% of mice in other groups survived. …”
-
20868
Analysis of the various EcFicTA complexes in solution.
Published 2016“…<p>(<i>a</i>) SEC-MALLS analysis of EcFicTA (green), EcFicTA<sub>E28G</sub> (pink), EcFicT<sub>G55R</sub>A (cyan) and EcFicT<sub>G55R</sub>A<sub>E28G</sub> (purple) reveals in each case a 1:1 complex in solution at an eluting concentration of 15 μM. …”
-
20869
S1 Data -
Published 2024“…Mean and SD of zinc in tissues from control and inoculated gerbils with two isolates of Giardia intestinalis: WB and HGINV. A significant decrease was present in zinc levels. …”
-
20870
-
20871
Related to Fig 3.
Published 2025“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX<sup>OE</sup> (mean ± SEM, <i>n</i> = 5) than BT-474_VECT<sup>OE</sup> tumors. …”
-
20872
-
20873
Discovery of a Novel Class of d‑Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform
Published 2022“…d-Serine is a coagonist of the <i>N</i>-methyl d-aspartate (NMDA) receptor, a key excitatory neurotransmitter receptor. …”
-
20874
-
20875
-
20876
Discovery of a Novel Class of d‑Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform
Published 2022“…d-Serine is a coagonist of the <i>N</i>-methyl d-aspartate (NMDA) receptor, a key excitatory neurotransmitter receptor. …”
-
20877
-
20878
Luminal tumors have a deregulated sphingolipid and ganglioside profile and high RICTOR expression.
Published 2025“…(<b>D</b>–<b>H</b>) Absolute quantification (mean ± SEM, <i>n</i> = 5) of GM3 (D), GD3 (E), GD2 (F), GM2 (G), and GM1 (H) gangliosides in luminal tumor tissues and adjacent normal tissues shows an increase in GM3 and GD3 gangliosides and a decrease in GM1 gangliosides in luminal tumor tissues. …”
-
20879
Feijoa F3 inhibits NF-κB activity in A. MEF cells and B. MEF Atg5<sup>-/-</sup> cells.
Published 2015“…A percentage of greater than 100 shows increased inflammatory response in the presence of the ligand when compared to media (no treatment); and a percentage of less than 100 suggests a decrease in the inflammatory response in the presence of the ligand when compared to media (no treatment) meaning that a condition has inhibited NF-κB signaling. …”
-
20880